newsfilter
← Latest News
Earnings Call Transcripts·

PHARVARIS CHAPTER-3 TOPLINE DATA - PHARVARIS NV

Welcome to the top-line data announcement of Chapter 3, a Phase 3 clinical study of Ducryptivant extended-release tablet for the prophylactic treatment of hereditary angioedema attacks. My name is Maggie Beller, Head of

Company
PHARVARIS NV
Keywords
PHARVARIS NV